Skip to main content

Advertisement

Table 3 Adverse events recorded during the study

From: Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa

Adverse events DP (n, %) AL (n, %) Total (n, %)
Abdominal pain 9 (4.6) 9 (4.8) 18 (4.7)
Dizziness 5 (2.5) 2 (1.1) 7 (1.8)
Diarrhoea 4 (2) 2 (1.1) 6 (1.6)
Vomiting 4 (2) 0 (0) 4 (1)
Pruritus 3 (1.5) 1 (0.5) 4 (1)
Nausea 2 (1) 2 (1.1) 4 (1)
Face oedema 1 (0.5) 0 (0) 1 (0.3)
Sleepiness 1 (0.5) 0 (0) 1 (0.3)
Insomnia 0 (0) 1 (0.5) 1 (0.3)